HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temozolomide: a novel treatment for pituitary carcinoma.

AuthorsStephen Lim, Hrayr Shahinian, Menahem M Maya, William Yong, Anthony P Heaney
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 7 Issue 6 Pg. 518-20 (Jun 2006) ISSN: 1470-2045 [Print] England
PMID16750503 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide
Topics
  • Aged
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Carcinoma (drug therapy, pathology, surgery)
  • Combined Modality Therapy
  • Dacarbazine (analogs & derivatives, therapeutic use)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Pituitary Neoplasms (drug therapy, pathology, surgery)
  • Temozolomide
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: